Frontlight ResearchEarly access
Macular degeneration trials in France
18 of 27 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Where
- Créteil, Dijon, Écully, Marseille, Paris, Saint-Cyr-sur-Loire
- Age
- 50 years and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07496567 - Phase 2Taking peopleEvaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.
- Where
- Amiens Cedex 1, Bobigny Cedex, Bordeaux, Chamant, Créteil, Dijon, Lyon, Lyon Cedex 04, Marseille, Montauban, Nantes, Nice, Paris 5e Arrondissement, Saint-Cyr-Sur-Loire, Saint-Priest-en-Jarez, Strasbourg, Toulouse Cedex 9, Tours, Valence
- Age
- 18 years and over
- People
- 162
- Run by
- Laboratoires Kol
See details and how to join2026-526775-27-00 - Phase 2Taking peopleA Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Where
- Bordeaux, Lyon Cedex 04, Marseille, Paris, Saint-Cyr-sur-Loire
- Age
- 55 years to 64 years
- People
- 110 worldwide
- Run by
- Galimedix Therapeutics Inc
See details and how to joinNCT06659549 · EU 2024-519128-26-00 - Phase 2Taking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Creteil Cedex, Dijon, Lyon Cedex 04, Paris, Saint-Cyr-Sur-Loire
- Age
- 50 years and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - Phase 3Taking peopleA Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
- Where
- Lyon, Montauban, Nantes, Paris, Poitiers, Strasbourg Cedex
- Age
- 50 years and over
- People
- 250 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06847542 · EU 2024-516924-32-00 - Phase 3Taking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Créteil, Dijon, Écully, Lille, Lyon Cedex 04, Marseille, Nantes, Nice, Paris Cedex 10, Poitiers, Rouen, Toulouse
- Age
- 50 years to 85 years
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - Phase 3Taking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Bordeaux, Créteil, Écully, Lyon, Marseille, Nantes, Nice, Paris
- Age
- 50 years and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - Phase 3Taking peopleExtension Study for the Port Delivery System With Ranibizumab (Portal)
- Where
- Bordeaux, Lyon Cedex 04, Marseille, Paris, Paris Cedex 10
- Age
- 50 years and over
- People
- 1,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT03683251 · EU 2023-507131-38-00 - Phase 3Active, not recruitingSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Where
- Marseille, Nantes, Nice
- Age
- 50 years and over
- People
- 480 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07064759 - Phase 2Active, not recruitingORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study
- Where
- Dijon, Nantes
- Age
- 55 years and over
- People
- 225 worldwide
- Run by
- Gyroscope Therapeutics Limited
See details and how to joinNCT05481827 · EU 2024-510946-15-00 - Phase 2/3Taking peopleA clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
- Where
- Créteil, Dijon, Écully, Lyon Cedex 04, Marseille, Paris, Saint-Cyr-Sur-Loire
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524894-17-00 - No phaseTaking peopleSurvival of Monocytes Collected From Patients With Atrophic AMD in Retinal Pigmented Epithelium Explants
- Where
- Lyon
- Age
- 15 years and over
- People
- 80
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT04697095 - Phase 2Taking peopleAn Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy
- Where
- La Tronche, Paris
- Age
- 65 years and over
- People
- 24
- Run by
- Eyevensys
See details and how to joinNCT07705568 · EU 2025-525008-12-00 - No phaseTaking peopleAcute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
- Where
- Toulon
- Age
- 18 years and over
- People
- 100
- Run by
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
See details and how to joinNCT06893965 - No phaseTaking peopleInternational Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study
- Where
- Marseille, Saint-Jean-de-Luz, Strasbourg
- Age
- 55 years and over
- People
- 44 worldwide
- Run by
- VisionCare, Inc.
See details and how to joinNCT07164378 - Phase 2Taking peopleLong-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy
- Where
- Créteil, Dijon, Lyon Cedex 04, Marseille, Nantes, Paris, Paris Cedex 10, Poitiers, Rouen, Saint-Cyr-Sur-Loire
- Age
- 55 years to 85 years
- People
- 90
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04292080 · EU 2024-510741-33-00 - No phaseTaking peopleHigh Resolution, High-speed Multimodal Ophthalmic Imaging
- Where
- Paris
- Age
- 18 years and over
- People
- 1,200
- Run by
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
See details and how to joinNCT04129021 - Phase 2Not yet taking people in FranceLong-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
- Where
- Créteil, Dijon, Lyon Cedex 04, Marseille, Montauban, Nantes, Nice, Paris, Toulouse
- Age
- 50 years and over
- People
- 865 worldwide
- Run by
- AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00